- Previous close
10.45 - Open
10.40 - Bid --
- Ask --
- Day's range
9.84 - 10.54 - 52-week range
8.22 - 27.05 - Volume
10,388,688 - Avg. Volume
20,180,751 - Market cap (intra-day)
8.538B - Beta (5Y monthly) 0.68
- PE ratio (TTM)
-- - EPS (TTM)
-10.01 - Earnings date 2 Jan 2025 - 6 Jan 2025
- Forward dividend & yield 1.00 (9.57%)
- Ex-dividend date 21 Aug 2024
- 1y target est
10.83
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com193,000
Full-time employees
31 August
Fiscal year ends
Healthcare
Sector
Pharmaceutical Retailers
Industry
Recent news: WBA
View more
Related videos: WBA
Performance overview: WBA
Trailing total returns as of 22/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: WBA
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: WBA
View moreValuation measures
Market cap
9.04B
Enterprise value
38.78B
Trailing P/E
--
Forward P/E
5.46
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.06
Price/book (mrq)
0.86
Enterprise value/revenue
0.26
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-5.85%
Return on assets (ttm)
0.15%
Return on equity (ttm)
-75.97%
Revenue (ttm)
147.66B
Net income avi to common (ttm)
-8.64B
Diluted EPS (ttm)
-10.01
Balance sheet and cash flow
Total cash (mrq)
3.11B
Total debt/equity (mrq)
277.90%
Levered free cash flow (ttm)
2.34B